Metraipolis › archive › dc_060c229f64eb

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer — Europe PMC PMID:41595162

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41595162
DOI
10.3390/cancers18020242
License (as archived)
solo-consultazione
Archived
2026-11-06T21:00:13.779Z
SHA-256 of the archived text
3743d30998430503788da769de9f174271403bacac1df931700c6506a6975453
Stable URL of this page
https://metraipolis.com/documento/dc_060c229f64eb

How to cite

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer — Europe PMC PMID:41595162 — Europe PMC (en), https://europepmc.org/article/MED/41595162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_060c229f64eb (Metraipolis archive dc_060c229f64eb, sha256 3743d30998430503788da769de9f174271403bacac1df931700c6506a6975453)
BibTeX
@misc{dc060c229f64eb,
  title = {Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer — Europe PMC PMID:41595162},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41595162},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_060c229f64eb; sha256 3743d30998430503788da769de9f174271403bacac1df931700c6506a6975453},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595162. Agents can read the archived copy with the MCP tool read_document.